What is Biohacking Market?
Biohacking which is also known as do-it-yourself biology science is an extremely broad and amorphous term that covers a huge range of activities. From performing the science experiments on yeast to the tracking of one's own sleep and diet for changing their own biology of the body by pumping a younger person's blood into the other person's blood veins in order to aging (young blood transfusion). The biohacking involves merging body modification with technology. Biohackers are involved in open source biology asserting who performs the art of changing the environment inside or outside the human body to hold control over its upgrading mind.
The market study is being classified by Type (Digital Health, Nutrition, Fitness, Meditation and Pharmaceuticals), by Application (Synthetic Biology, Genetic Engineering, Forensic Sciences and Others) and major geographies with country level break-up.
uBiome (United States), Soylent Nutrition, Inc. (United States), Fitbit, Inc. (United States), Neuralink Corporation (United States), Nootrobox (HVMN) (United States), Thync Global Inc. (United States), Synbiota (Canada), DNA Fit (United Kingdom), The ODIN (United States) and Behavioural Technology Inc. (Pavlok) (United States) are some of the key players profiled in the study.
Segment Analysis
Analyst at AMA have segmented the market study of Global Biohacking market by Type, Application and Region.
On the basis of geography, the market of Biohacking has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Demand for Digital Health and Fitness
- Awareness about Mental and Physical Health
Market Trend
- The Advent of Microchips, Sensors and Other Wearables to Regulate the Sleep and Other Health Patterns
- Increasing Consumption of Nutriritand Healthy Food and Supplements for Biohacking
Restraints
- Safety Risks Associated with Biohacking
- Stringent Regulatory Compliances with Biohacking
Opportunities
- Availability of Biohacking Supplements Online will Boos the Market
- High Potential Innovations in Biohacking
Challenges
- Expensive Biohacking Devices
On 23rd April 2019, DNA Fit launched the new Health Fit test, featuring most in-depth reports yet on sleep and stress genetics alongside diet and fitness insights. This test explores the number of genetic factors that can affect wellbeings such as sleep quality and the personal impact of caffeine on sleep. Analyzing six specific genes that combine to generate the customer’s ‘chronotype’, this assesses whether a person is genetically predisposed to heighten hormonal activity in the morning or evening.
"The U.S. Food and Drug Administration (FDA), for example, has extensive power to regulate the public health impacts of genetic biohacking, with jurisdiction that reaches farther than many biohackers realize. In many circumstances, the things used by genetic biohackers—such as raw biological materials, traditional drug products, and DIY CRISPR kits—are, by statute, FDA-regulatable drugs."
Key Target Audience
Biohacking Device Manufacturers, Research and Development Institutes, National Laboratories, Financial Institutes and Venture Capital, Regulatory Bodies and Others